Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for osteolytic lesion activity in revision total hip arthroplasty
2011-000541-20Phase 2Unknown
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteolysis and aseptic loosening of hip arthroplasty (ALHA) comparing Denosumab with Placebo (2 arms). Status: unknown.
02
Drugs
denosumab
03
Conditions
osteolysisaseptic loosening of hip arthroplasty (ALHA)
Beyond the preview
Go deeper on 2011-000541-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000541-20.